Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:1545-1549
Published online before print March 10, 2008, doi: 10.1161/CIRCULATIONAHA.107.737841
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
117/12/1545    most recent
CIRCULATIONAHA.107.737841v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Sagristà-Sauleda, J.
Right arrow Articles by Permanyer-Miralda, G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sagristà-Sauleda, J.
Right arrow Articles by Permanyer-Miralda, G.
Related Collections
Right arrow Other heart failure
Right arrow Other Treatment
Right arrowRelated Article

(Circulation. 2008;117:1545-1549.)
© 2008 American Heart Association, Inc.


Heart Failure

Hemodynamic Effects of Volume Expansion in Patients With Cardiac Tamponade

Jaume Sagristà-Sauleda, MD; Juan Angel, MD; Antonia Sambola, MD; G. Permanyer-Miralda, MD

From Servei de Cardiologia, hospital Universitari Vall d’Hebron (J.S.-S., J.A., A.S., G.P.-M.) and Ciber de Epidemiología y Salud Pública (CIBERESP) (G.P.-M), Barcelona, Spain.

Correspondence to Dr Jaime Sagristá Sauleda, Servei de Cardiologia, Hospital Universitari Vall d’Hebron, P. Vall d’Hebron 119-129, 08035 Barcelona, Spain. E-mail jsagrist{at}vhebron.net

Received September 18, 2007; accepted January 23, 2008.

Background— Volume expansion has been proposed as an alternative treatment for cardiac tamponade; however, the scientific evidence for this recommendation is very poor.

Methods and Results— Forty-nine unselected patients (23 males; age 55±16 years) with large pericardial effusion and hemodynamic tamponade underwent fluid overload with intravenous administration of 500 mL of normal saline over 10 minutes. Cardiac index and intrapericardial, left ventricular end-diastolic, right atrial, and right ventricular end-diastolic pressures were measured during basal state (tamponade), after fluid overload, and after pericardiocentesis. Twenty-eight patients (57%) had physical signs of tamponade, and 10 (20%) were hypotensive. Size of pericardial effusion was 31±13 mm. Initial mean arterial pressure was 88±21 mm Hg, and cardiac index was 2.46±0.80 L · min–1 · m–2. Intrapericardial pressure was 8.31±5.98 mm Hg. Volume expansion caused a significant increase in mean arterial pressure (from 88±21 to 94±23 mm Hg, P=0.003) and cardiac index (from 2.46±0.80 to 2.64±0.68 L · min–1 · m–2, P=0.013), as well as in intrapericardial pressure (from 8.31±5.98 to 11.02±6.27 mm Hg, P=0.0001), right atrial pressure (from 9.76±5.91 to 12.82±6.34 mm Hg, P=0.0001), and left ventricular end-diastolic pressure (from 14.21±5.97 to 19.48±6.19 mm Hg, P=0.0001). Cardiac index increased by >10% in 23 patients (47%), remained unchanged in 11 (22%), and decreased in 15 (31%). No patient developed clinical complications. Predictors of this favorable response were systolic blood pressure <100 mm Hg and low cardiac index.

Conclusions— Approximately one half of patients with cardiac tamponade develop a significant increase in cardiac output after volume overload. Low systolic blood pressure (<100 mm Hg) at baseline was the simplest clinical finding that was predictive of this favorable response.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 1499. [Full Text]